Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Leases (2022 - 2025)

Oncology Institute's Current Leases history spans 4 years, with the latest figure at $7.2 million for Q4 2025.

  • For Q4 2025, Current Leases rose 5.27% year-over-year to $7.2 million; the TTM value through Dec 2025 reached $7.2 million, up 5.27%, while the annual FY2025 figure was $7.2 million, 5.27% up from the prior year.
  • Current Leases reached $7.2 million in Q4 2025 per TOI's latest filing, roughly flat from $7.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $7.2 million in Q3 2025 to a low of $4.3 million in Q1 2022.
  • Average Current Leases over 4 years is $6.1 million, with a median of $6.4 million recorded in 2023.
  • Peak YoY movement for Current Leases: soared 33.77% in 2023, then grew 5.27% in 2025.
  • A 4-year view of Current Leases shows it stood at $5.5 million in 2022, then rose by 15.73% to $6.4 million in 2023, then grew by 6.84% to $6.8 million in 2024, then increased by 5.27% to $7.2 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Current Leases are $7.2 million (Q4 2025), $7.2 million (Q3 2025), and $7.0 million (Q2 2025).